drugset / Trial / NCT07128641
Odronextamab in Low Tumor Volume Advanced FL
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of treating previously untreated Follicular Lymphoma (FL) with odronextamab. The name of the study drug in this research study is: -Odronextamab (a type of monoclonal antibody)
Timeline
- Start
- 2025-09-08
- Primary completion
- 2027-01-02
- Completion
- 2028-01-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Odronextamab | Monoclonal antibody | — | Intravenous |